Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Palladium-103 brachytherapy for prostate carcinoma.
Blasko JC, Grimm PD, Sylvester JE, Badiozamani KR, Hoak D, Cavanagh W. Blasko JC, et al. Among authors: badiozamani kr. Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):839-50. doi: 10.1016/s0360-3016(99)00499-x. Int J Radiat Oncol Biol Phys. 2000. PMID: 10705004
Comparability of CT-based and TRUS-based prostate volumes.
Badiozamani KR, Wallner K, Cavanagh W, Blasko J. Badiozamani KR, et al. Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):375-8. doi: 10.1016/s0360-3016(98)00418-0. Int J Radiat Oncol Biol Phys. 1999. PMID: 10030264
Anticipating prostatic volume changes due to prostate brachytherapy.
Badiozamani KR, Wallner K, Sutlief S, Ellis W, Blasko J, Russell K. Badiozamani KR, et al. Radiat Oncol Investig. 1999;7(6):360-4. doi: 10.1002/(SICI)1520-6823(1999)7:6<360::AID-ROI6>3.0.CO;2-D. Radiat Oncol Investig. 1999. PMID: 10644059 Clinical Trial.
Standardization of prostate brachytherapy treatment plans.
Ove R, Wallner K, Badiozamani K, Korjsseon T, Sutlief S. Ove R, et al. Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):257-63. doi: 10.1016/s0360-3016(01)01471-7. Int J Radiat Oncol Biol Phys. 2001. PMID: 11316571 Clinical Trial.
Permanent prostate brachytherapy using high V150.
Serrano NA, Pham HT, Narayanan S, Badiozamani KR. Serrano NA, et al. Among authors: badiozamani kr. Pract Radiat Oncol. 2015 May-Jun;5(3):e201-e206. doi: 10.1016/j.prro.2014.06.008. Epub 2014 Aug 7. Pract Radiat Oncol. 2015. PMID: 25413406 Clinical Trial.
Blood-based detection of radiation exposure in humans based on novel phospho-Smc1 ELISA.
Ivey RG, Moore HD, Voytovich UJ, Thienes CP, Lorentzen TD, Pogosova-Agadjanyan EL, Frayo S, Izaguirre VK, Lundberg SJ, Hedin L, Badiozamani KR, Hoofnagle AN, Stirewalt DL, Wang P, Georges GE, Gopal AK, Paulovich AG. Ivey RG, et al. Among authors: badiozamani kr. Radiat Res. 2011 Mar;175(3):266-81. doi: 10.1667/RR2402.1. Epub 2010 Dec 20. Radiat Res. 2011. PMID: 21388270 Free PMC article.
Duration of androgen suppression in prostate cancer.
Badiozamani KR. Badiozamani KR. N Engl J Med. 2009 Sep 17;361(12):1212; author reply 1212-3. doi: 10.1056/NEJMc091433. N Engl J Med. 2009. PMID: 19759384 No abstract available.
Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621.
Hurwitz MD, Harris J, Sartor O, Xiao Y, Shayegan B, Sperduto PW, Badiozamani KR, Lawton CAF, Horwitz EM, Michalski JM, Roof K, Beyer DC, Zhang Q, Sandler HM. Hurwitz MD, et al. Among authors: badiozamani kr. Cancer. 2017 Jul 1;123(13):2489-2496. doi: 10.1002/cncr.30620. Epub 2017 Mar 21. Cancer. 2017. PMID: 28323339 Free PMC article.